(NASDAQ: PROF) Profound Medical's forecast annual revenue growth rate of 113.07% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.09%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.52%.
Profound Medical's revenue in 2024 is $5,293,382.On average, 4 Wall Street analysts forecast PROF's revenue for 2024 to be $235,610,479, with the lowest PROF revenue forecast at $224,390,933, and the highest PROF revenue forecast at $252,172,667. On average, 4 Wall Street analysts forecast PROF's revenue for 2025 to be $637,911,365, with the lowest PROF revenue forecast at $373,984,888, and the highest PROF revenue forecast at $961,675,425.
In 2026, PROF is forecast to generate $1,105,114,657 in revenue, with the lowest revenue forecast at $564,182,916 and the highest revenue forecast at $1,844,279,760.